Cyclerion Therapeutics Profit Margin 2018-2021 | CYCN
Current and historical gross margin, operating margin and net profit margin for Cyclerion Therapeutics (CYCN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cyclerion Therapeutics net profit margin as of June 30, 2021 is -1880.97%.
|Cyclerion Therapeutics Annual Profit Margins
|Cyclerion Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Cyclerion Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's product pipeline consists of Olinciguat, Praliciguat and IW-6463 which are in clinical stage. Cyclerion Therapeutics Inc. is based in Cambridge, United States.